Bristol-Myers Squibb: Diabetes Mellitus trials

The registry lists 17 Diabetes Mellitus studies with Bristol-Myers Squibb as lead sponsor. 0 are open to participants now and 1 have results posted.

Phase 1 6Phase 2 3Phase 3 6Phase 4 2No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 DiabetesCompletedNCT01864174Phase 4Results posted
• Japanese Phase 1 Multiple Ascending Dose StudyCompletedNCT01515202Phase 1
• Multiple Ascending Dose Study of BMS-820132 in Patients With Type 2 DiabetesCompletedNCT01290575Phase 1
• Safety Study of BMS-903452 in Healthy Subjects (Panel 1-7) & Relative Bioavailability of the Crystalline and Amorphous Forms of BMS-903452 [Panels 4, 6, 11 & 12(Part A)], and Subjects With Type 2 Diabetes Mellitus (Part B)CompletedNCT01240980Phase 1
• Safety Study of BMS-823778 in Subjects With Type 2 DiabetesCompletedNCT01111955Phase 2
• Single Ascending Dose Study of BMS-820132 in Patients With Type 2 DiabetesCompletedNCT01105429Phase 1
• Safety Study of BMS-770767 in Subjects With Type 2 DiabetesCompletedNCT01046422Phase 2
• Safety Study to Evaluate BMS-767778 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus (T2DM)TerminatedNCT00707590Phase 1
• Expanded Access for Metreleptin for the Treatment of Diabetes Mellitus and/or Hypertriglyceridemia Associated With LipodystrophyNo longer availableNCT00677313
• Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-686117 in Subjects With Type 2 DiabetesCompletedNCT00508287Phase 1
• A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic ControlCompletedNCT00246987Phase 3
• Dose Ranging Study With LT, Monotherapy, PPARCompletedNCT00240383Phase 2/3
• PPAR - Combination With MetforminCompletedNCT00162240Phase 3
• PPAR-COMBO With SulfonylureaCompletedNCT00162175Phase 3
• Study of Muraglitazar Versus Pioglitazone in Type 2 DiabetesCompletedNCT00106808Phase 3
• A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 DiabetesCompletedNCT00035568Phase 4
• A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.CompletedNCT00035542Phase 3